3rd European Prefilled Syringes Summit
19 September 2018 - 20 September 2018
After the two successful ACI's European Prefilled Syringes Summit, we are pleased to announce the next edition which shall take place on the 19th & 20th September in Berlin, Germany.
The event will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation , portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
There are several elements that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and needle stick prevention.
Berlin, Germany
http://www.wplgroup.com/aci/event/european-prefilled-syringes-summit/
Immuno-oncology Conference
26 September 2018 - 27 September 2018
SMi's Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress. In discussions:
• Targeting immune checkpoints with Humabody VH therapeutics
• Recent advances in providing durable disease control with Keytruda
• Tumour mutation burden and the potential of its use
• Unwanted immunogenicity and functionality testing
Amongst speakers are representatives of Crescendo Biologics, MHRA, Gilead Sciences, MedImmune, Exicure, MSD, AstraZeneca and many others
Copthorne Tara Hotel, London, UK
http://www.immuno-oncology-conference.com/ddtwl
Biosimilars & Biobetters 2018
26 September 2018 - 27 September 2018
The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK. Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018, SMi deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.
After over a decade, the biosimilars industry is finally reaching a stage where key stakeholders understand and accept biosimilars. This is reflected in more tolerant legislation and an increased uptake of biosimilars across the globe.
We are now entering a very exciting time, for over the next few years several originator patents are expiring, and we will see the next few waves of biosimilars enter the market. Will the biosimilar be a successful contender and spark a competitive environment or the originator dominate? Have we done enough to convince the payer, prescriber and patient to switch?
Join us to hear experiences of key opinion leaders and evaluate market access, opportunities and commercialisation strategies with industry-thought experts.
This event is CPD accredited.
Copthorne Tara Hotel, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/biosimilars-and-biobetters?utm_medium=www.biosimilars-europe.com&utm_source=P-263&utm_campaign=DrugDToday